Mid-Day Traders: Alcoa Inc (NYSE:AA), Johnson & Johnson (NYSE:JNJ)  

Active Stocks

Shares of Alcoa Inc (NYSE:AA), slanted 2.12% to $9.65, amid its last exchanging session.


Alcoa Inc. (Alcoa) is occupied with lightweight metals designing and assembling. The Company works in four portions: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. Its items, which contain aluminum, titanium and nickel, are utilized as a part of flying machine, autos, business transportation, bundling, building and development, oil and gas, barrier, purchaser hardware, and modern applications over the world.

The Board of Directors of Alcoa proclaimed (an) a quarterly basic stock profit of 3 pennies for each offer payable November 25, 2015 to holders of record of the regular stock at the end of business on November 6, 2015; and (b) a profit of 93.75 pennies for every offer on Alcoa’s $3.75 combined favored stock (“Class A Stock”) payable January 1, 2016 to holders of record of the Class A Stock at the end of business on December 11, 2015.

Shares of Johnson & Johnson (NYSE:JNJ), slanted 0.30% to $93.32, amid its last exchanging session.

Johnson & Johnson is a holding organization. The Company is occupied with the innovative work, assembling and offer of a scope of items in the medicinal services field. The Company has more than 265 working organizations directing business around the globe.

Johnson & Johnson will have a phone call for financial specialists at 8:30 a.m. (Eastern Time) on Tuesday, Oct. thirteenth, to audit second from last quarter results. Gary Pruden, Worldwide Chairman, Medical Devices; Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor Relations, will have the call.

Notes to the Stakeholders:

This article is the intellectual property of www.jbhnews.com. The purpose of penning down this article has been just to share information. Moreover, it is firmly believed that all the information that are revealed in this article are from reliable sources, however, we do not make any representations or warranties whatsoever of any kind, express or implied, as far as the completeness, accurateness, or reliability with respect to this article is concerned.

All the respectable visitors to this website are kindly advised to conduct their own independent research into individual stocks prior to making a purchase decision.

This article contains an advanced information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as well as statements regarding the forseeable frequent growth of the market for the corporation’s products, the corporation’s capability to fund its capital requirement in the close-to term and in the long term; pricing pressures; etc.

Furthermore, any statement that expresses or involves discussions with respect to forecast, expectations, beliefs, strategy, projection, objectives, aims, assumption, or future events or performance may be forward looking statements. In addition, the forward-looking statements are wholly and solely based upon expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. An easy way to identify the forward looking statements is through the use of such words as be expecting, will, foresee, guess, considered, or by statements that indicates certain actions may, could, should/might occur.


About the Author

Kristen Rose
University graduate with a bachelor's degree in business administration. Kristen is the Finance Editor, overseeing markets, economics, wealth, fintech, banking, and regulation coverage, based in London. She like to keep things simple, enjoy life, & appreciate everything around me.♡